补肾方治疗骨痹证（肾虚型）的临床观察及相关指标测定
|
摘要
第一部分补肾方治疗膝关节骨性关节炎合并滑膜炎的临床观察
目的:观察补肾中药治疗膝关节骨性关节炎(OA)合并滑膜炎的临床疗效和安全性。
方法:选择83例膝关节OA合并滑膜炎患者,随机分为治疗组及对照组:治疗组应用补肾中药青娥丸加味片;对照组应用消炎止痛(NSAIDs)西药奥湿克,两组均辅以患肢制动或抽取关节腔积液疗法,疗程1个月,并观察了患者治疗前后关节疼痛、晨僵、关节肿胀、关节压痛、关节功能等变化。
结果:治疗组和对照组治疗后症状体征均有明显改善,治疗前后差异明显(P＜0.01)。治疗组改善晨僵及关节肿胀症状明显优于对照组(P＜0.05);且副作用与对照组比较差异显著。
结论:补肾中药治疗膝关节OA不仅能改善患者症状体征,而且不良反应少,值得临床推广应用。
第二部分补肾方治疗骨质疏松症合并骨关节炎的作用机理研究
目的:探讨补肾方对骨质疏松症合并骨关节炎的作用机理。
方法:采用补肾中药青娥丸加味片治疗50例骨质疏松症合并骨关节炎患者,疗程为三个月,同时观察患者治疗前后症状体征、骨密度的变化,并检测患者血清IL-6、TNF-α水平。
结果:在补肾中药作用下,患者症状及体征缓解,骨密度稍升高,血清IL-6、TNF-α水平下降。
结论:补肾中药可能通过增加骨密度、影响细胞因子从而治疗骨质疏松症合并骨关节炎患者。
第三部分补肾活血方治疗酒精性股骨头坏死的临床观察
目的:研究补肾活血中药对酒精性股骨头坏死患者的治疗作用和血液流变学的影响。
方法:选择酒精性股骨头坏死患者32例,采用补肾活血中药内服治疗3月,检测患者治疗前后症状体征及血液流变学的变化。
结果:治疗后患者症状体征及功能活动均较治疗前有改善;治疗后全血比粘度、血浆比粘度、红细胞压积、红细胞电泳时间均明显降低,与治疗前比较有显著性差异(P＜0.05)。
结论:补肾活血中药可改善股骨头处的供血,促进坏死股骨头的修复。
第四部分补肾活血方对兔股骨头缺血性坏死的治疗作用与机理研究
目的:研究补肾活血中药治疗股骨头缺血性坏死的作用机理。
方法:选择24只大白兔,采用冷冻法制作成股骨头缺血性坏死模型,并随机分为3组:治疗组、对照组、模型组。治疗组和对照组分别给予补肾活血中药和左旋多巴灌胃,模型组灌服生理盐水,一月后处死兔,测量其股骨头的骨密度、生物力学和血清血管内皮生长因子(VEGF)浓度的变化。
结果:补肾中药组能明显增加模型兔血清中VEGF浓度、骨密度和生物力学性质,与对照组及模型组比较有显著差异(P＜0.01)。
结论:补肾活血中药可增加股骨头缺血性坏死兔骨组织骨密度,提高生物力学强度,该复方中药治疗股骨头缺血性坏死的作用可能与其能提高血清中VEGF的浓度有关。
PARTⅠThe Clinical Observation of Combination of Chinese Traditional and Western Medicine to Treat Knee Joint Osteoarthritis complicating by Synovitis
Aim:To observe the clinical effect and security of combination of Chinese traditional and western medicine on knee joint osteoarthritis(OA) complicating by synovitis.
Methods:83 cases of knee joint OA complicating by Synovitis were randomly divided into treated group and control group.The treated group was used Qinger tablet and the control group was used Aoshike.Two groups were hold knees in place or drawn liquid from cavum articulare as auxiliary measure.The course of treatment was one month.The symptoms and physical signs were observed before and after treatment.
Result:The symptoms and physical signs were improved after treatment.There was obviously difference before and after treatment(p＜0.01).Some symptoms and physical signs of the treated group such as arthralgia and joint's stiff in the morning were superior to that of the control group(p＜0.05).The adverse reaction was obviously difference between two groups.
Conclusion:The knee joint OA was treated with combination of Chinese traditional and western medicine.Not only the symptoms and physical signs were improved,but also the adverse reaction was small and slight.So Qinger tablet is worth being popularized and applied in clinical.
PARTⅡThe Mechanism Research of Kidney Invigoration on Osteoarthritis and Osteoporosis
Objective:To probe into the mechanism of kidney invigoration on osteoarthrosis and osteoporosis.
Methods:50 cases of osteoarthritis and osteoporosis were treated with,Qinger tablet, Traditional Chinese medicinal drug of kidney invigoration.The course of treatment was three months.At the same time,the symptoms,signs,bone mineral density were observed in treatment before and after.The serum levels of IL-6 and TNF-a were measured.
Results:It was showed that osteodynia symptoms were improved,bone mineral density was increased.The serum levels of IL-6 and TNF-a was lower than that of pretreatment.
Conclusions:The Traditional Chinese medicinal drug of Kidney invigoration could increase the patients' bone mineral density and affect IL-6 and TNF-a secretion to treat Osteoarthritis and Osteoporosis.
PARTⅢThe Clinical Observation of Bushen Huoxuefang to Treat Necrosis of Femoral Head Caused by Alcohol
Objective:To study on the effects of blood rheology and treatment on patients with necrosis of femoral head caused by alcohol using Bushen Huoxuefang(BSHXF).
Methods:32 patients were selected in this study,and they were treated continuing 3 months with BSHXF.The changes of blood rheology and symptoms were measured before and after treatment of BSHXF.
Results:Blood viscosity,plasma viscosity,electrophoresis time of RBC and hematocrit of patients after treatment were lower than that before treatment,and there were significant statistical differences between both.(P＜0.05).
Conclusion:BSHXF might improve the blood circulation in the region of femoral head and promote repair of femoral head necrosis
PARTⅣThe Treatment Effect and Mechanism Research of Experimental Rabbits With Avascular Necrosis of Femoral Head Treated by Bushenhuoxuefang
Objective:To study the mechanism of avascular necrosis of femoral head treated by bushenhuoxuefang
Methods:24 rabbits' left femoral heads were induced by freezing with liquid nitrogen. At the same time,they were randomly divided into three groups:the Traditional Chinese medicine group,the levodopa group and the model group.Traditional Chinese medicine group and levodopa group were treated continuing one month.Bone mineral density and Biomechanical index of femoral head and serum VEGF concentration were measured after rabbits being sacrificed.
Results:Femoral head of bone mineral density,serum VEGF concentration and the Biomechanical index in the traditional Chinese medicine group had significant statistical differences contrast with that of levodopa group and model group.(P＜0.01)
Conclusion:The traditional Chinese medicine bushenhuoxuefang can increase bone density and biomechanical strength of the experimental rabbits with avascular necrosis of femoral head.The treatment might attributed to it can increase the serum VEGF concentration.
目的:观察补肾中药治疗膝关节骨性关节炎(OA)合并滑膜炎的临床疗效和安全性。
方法:选择83例膝关节OA合并滑膜炎患者,随机分为治疗组及对照组:治疗组应用补肾中药青娥丸加味片;对照组应用消炎止痛(NSAIDs)西药奥湿克,两组均辅以患肢制动或抽取关节腔积液疗法,疗程1个月,并观察了患者治疗前后关节疼痛、晨僵、关节肿胀、关节压痛、关节功能等变化。
结果:治疗组和对照组治疗后症状体征均有明显改善,治疗前后差异明显(P＜0.01)。治疗组改善晨僵及关节肿胀症状明显优于对照组(P＜0.05);且副作用与对照组比较差异显著。
结论:补肾中药治疗膝关节OA不仅能改善患者症状体征,而且不良反应少,值得临床推广应用。
第二部分补肾方治疗骨质疏松症合并骨关节炎的作用机理研究
目的:探讨补肾方对骨质疏松症合并骨关节炎的作用机理。
方法:采用补肾中药青娥丸加味片治疗50例骨质疏松症合并骨关节炎患者,疗程为三个月,同时观察患者治疗前后症状体征、骨密度的变化,并检测患者血清IL-6、TNF-α水平。
结果:在补肾中药作用下,患者症状及体征缓解,骨密度稍升高,血清IL-6、TNF-α水平下降。
结论:补肾中药可能通过增加骨密度、影响细胞因子从而治疗骨质疏松症合并骨关节炎患者。
第三部分补肾活血方治疗酒精性股骨头坏死的临床观察
目的:研究补肾活血中药对酒精性股骨头坏死患者的治疗作用和血液流变学的影响。
方法:选择酒精性股骨头坏死患者32例,采用补肾活血中药内服治疗3月,检测患者治疗前后症状体征及血液流变学的变化。
结果:治疗后患者症状体征及功能活动均较治疗前有改善;治疗后全血比粘度、血浆比粘度、红细胞压积、红细胞电泳时间均明显降低,与治疗前比较有显著性差异(P＜0.05)。
结论:补肾活血中药可改善股骨头处的供血,促进坏死股骨头的修复。
第四部分补肾活血方对兔股骨头缺血性坏死的治疗作用与机理研究
目的:研究补肾活血中药治疗股骨头缺血性坏死的作用机理。
方法:选择24只大白兔,采用冷冻法制作成股骨头缺血性坏死模型,并随机分为3组:治疗组、对照组、模型组。治疗组和对照组分别给予补肾活血中药和左旋多巴灌胃,模型组灌服生理盐水,一月后处死兔,测量其股骨头的骨密度、生物力学和血清血管内皮生长因子(VEGF)浓度的变化。
结果:补肾中药组能明显增加模型兔血清中VEGF浓度、骨密度和生物力学性质,与对照组及模型组比较有显著差异(P＜0.01)。
结论:补肾活血中药可增加股骨头缺血性坏死兔骨组织骨密度,提高生物力学强度,该复方中药治疗股骨头缺血性坏死的作用可能与其能提高血清中VEGF的浓度有关。
PARTⅠThe Clinical Observation of Combination of Chinese Traditional and Western Medicine to Treat Knee Joint Osteoarthritis complicating by Synovitis
Aim:To observe the clinical effect and security of combination of Chinese traditional and western medicine on knee joint osteoarthritis(OA) complicating by synovitis.
Methods:83 cases of knee joint OA complicating by Synovitis were randomly divided into treated group and control group.The treated group was used Qinger tablet and the control group was used Aoshike.Two groups were hold knees in place or drawn liquid from cavum articulare as auxiliary measure.The course of treatment was one month.The symptoms and physical signs were observed before and after treatment.
Result:The symptoms and physical signs were improved after treatment.There was obviously difference before and after treatment(p＜0.01).Some symptoms and physical signs of the treated group such as arthralgia and joint's stiff in the morning were superior to that of the control group(p＜0.05).The adverse reaction was obviously difference between two groups.
Conclusion:The knee joint OA was treated with combination of Chinese traditional and western medicine.Not only the symptoms and physical signs were improved,but also the adverse reaction was small and slight.So Qinger tablet is worth being popularized and applied in clinical.
PARTⅡThe Mechanism Research of Kidney Invigoration on Osteoarthritis and Osteoporosis
Objective:To probe into the mechanism of kidney invigoration on osteoarthrosis and osteoporosis.
Methods:50 cases of osteoarthritis and osteoporosis were treated with,Qinger tablet, Traditional Chinese medicinal drug of kidney invigoration.The course of treatment was three months.At the same time,the symptoms,signs,bone mineral density were observed in treatment before and after.The serum levels of IL-6 and TNF-a were measured.
Results:It was showed that osteodynia symptoms were improved,bone mineral density was increased.The serum levels of IL-6 and TNF-a was lower than that of pretreatment.
Conclusions:The Traditional Chinese medicinal drug of Kidney invigoration could increase the patients' bone mineral density and affect IL-6 and TNF-a secretion to treat Osteoarthritis and Osteoporosis.
PARTⅢThe Clinical Observation of Bushen Huoxuefang to Treat Necrosis of Femoral Head Caused by Alcohol
Objective:To study on the effects of blood rheology and treatment on patients with necrosis of femoral head caused by alcohol using Bushen Huoxuefang(BSHXF).
Methods:32 patients were selected in this study,and they were treated continuing 3 months with BSHXF.The changes of blood rheology and symptoms were measured before and after treatment of BSHXF.
Results:Blood viscosity,plasma viscosity,electrophoresis time of RBC and hematocrit of patients after treatment were lower than that before treatment,and there were significant statistical differences between both.(P＜0.05).
Conclusion:BSHXF might improve the blood circulation in the region of femoral head and promote repair of femoral head necrosis
PARTⅣThe Treatment Effect and Mechanism Research of Experimental Rabbits With Avascular Necrosis of Femoral Head Treated by Bushenhuoxuefang
Objective:To study the mechanism of avascular necrosis of femoral head treated by bushenhuoxuefang
Methods:24 rabbits' left femoral heads were induced by freezing with liquid nitrogen. At the same time,they were randomly divided into three groups:the Traditional Chinese medicine group,the levodopa group and the model group.Traditional Chinese medicine group and levodopa group were treated continuing one month.Bone mineral density and Biomechanical index of femoral head and serum VEGF concentration were measured after rabbits being sacrificed.
Results:Femoral head of bone mineral density,serum VEGF concentration and the Biomechanical index in the traditional Chinese medicine group had significant statistical differences contrast with that of levodopa group and model group.(P＜0.01)
Conclusion:The traditional Chinese medicine bushenhuoxuefang can increase bone density and biomechanical strength of the experimental rabbits with avascular necrosis of femoral head.The treatment might attributed to it can increase the serum VEGF concentration.
引文
1.Resnick D.Diagnosis of Bone and Joint Disorders[M].4th ed.北京:人民卫生出版社,2002:1269-1271.
2.Zhang,Y,Hunter DJ,Nevitt MC,et al.Association of squatting with increased prevalence of radiographic tibiofemoral knee osteoarthritis[J].Arthritis Rheum,2004(50):1187-1192.
3.邵俊杰.细胞因子与骨关节炎J.国外医学:骨科学分册,2001,3:143-146.
4.Jiang Q,Shi D,Yi L,et al.Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese.J Hum Genet.2006;51(12):1068-72.
5.Mustafa Z,Dowling B,Chapman,et al.Investigating the aspartic acid(D) repeat of asporin as a risk factor for osteoarthritis in a UK Caucasian population.Arthritis Rheum.2005 Nov;52(ll):3502-6.
6.Rodriguez-Lopez J,Pombo-Suarez M,Liz M,et al.Lack of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility:case-control studies in Spanish Caucasians.Arthritis Res Ther.2006;8(3):R55.
7.刘林英.股骨头坏死分析.中国疗养医学.2007,16(7):447.
8.王凤仪,马在山,马素英等.山东中部地区人群股骨头坏死流行病学调查研究.中国骨伤.2001,14(6):345-346.
9.高广凌,王亮,黄相杰.股骨头坏死误诊27例分析.中国误诊学杂志.2007,7(24):5813-5814.
10.张旭,王衡.早期股骨头缺血性坏死误诊原因分析.医药论坛杂志.2007,28(13):33-34.
11.谢大成.102例股骨头无菌性坏死的病因分析.中国保健.2007,15(17):38.
12.王学谦,李秀兰,师宜健等.甲基强的松龙冲击疗法引发股骨头缺血性坏死的实验研 究.2007,27(11):849-854.
13.袁洁.692例股骨头缺血性坏死病因调查分析,广州中医药学院院报,1994,11(1):29.
14.Ohzono K,Saito M,Takaoka K.Natural history of nontraumatic avascular necrosis of the femoral head.J Bone Joint Surg Br.1991,73(1):68-72.
15.李盛华,姚正凯.激素性股骨头坏死细胞凋亡的实验研究进展.甘肃中医.2007,20(9):61-62.
16.田刚,王大伟.酒精性股骨头缺血性坏死发病机制的研究近况.辽宁中医学院学报.2005,7(6):570-571.
17.Xiong M,Wang K,Dang X.An experimental study on osteocyte apoptosis in steroid-induced early osteonecrosis of femoral head.Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi,2007,21:262-265.
1.吴阶平,裘法祖主编,黄家驷外科学第六版北京:人民卫生出版社2131
2.张乃峥,施全胜,张雪哲,等.膝骨关节炎的流行病学调查.中华内科杂志,1995,34(2):84-87.
3.曾庆馀,黄少弼,肖征宇,等.症状性骨关节的临床和流行病学探讨.中华内科杂志,1995,34(1):88.
4.Spector TD,Hart DJ,Doyle DR et al.Incidence and progression of osteoarthritis in women with unilateral knee disease in the general population:the effect of ebesity.Ann Rheum Dis.1994:53(1):565.
5.叶永平.膝关节骨关节炎致病因素研究.国外医学·创伤与外科基本问题分册,1999,20(1):1-3.
6.路志正,焦树德主编,实用中医风湿病学北京:人民卫生出版社1996,608-619.
1.魏泉洁,蒋位庄,张晓铀.骨质疏松症与退行性骨关节病相关性实验研究.中国骨伤,1997,12(4):14-17.
2.Healey JH,Vigorita VJ,Lane JM.The coexistance and characteristics of osteoarthritis and osteoporosis.J Bone joint Sury,1985,67(1):586.
3.Hart DJ,Mootoosamy I,Doyle DV,et al.The relationship between osteoarthritis and osteoporosis in the general population:The Chinford Study.Ann Rheum Dis,1994,53(1),158.
4.王雪飞.骨关节炎与骨质疏松相关性研究.中国骨质疏松杂志,1999,5(3):73-76.
5.张银桃,唐建明,侯亚平.骨关节炎与骨质疏松症关系的研究.中国现代医学杂志,1996,6(3):9-10.
6.丁仁奎,孙材江,王万春.膝关节退行性骨关节病与骨质疏松的相关关系研究.湖南医学,1997,14(6):323-324.
7.戴力扬.脊柱骨关节炎与骨质疏松的关系.中国矫形外科杂志,1997,4(5):364-365.
8.Zheng SX,Vrindts Y,Lopez M,et al.Increase in cytokine production by stimulated whole blood cells in postmenopausal osteoporosis.Maturitas,1997,26(1):63.
9.Goldring,-m-b.The role of cytokines as inflammatory mediators in osteoarrthritis:lessons from animal models.Connect-Tissue-Res.1999,40(1):1-11.
10.Moos,-V;Fickert,-S;Muller,-B.Immunohistological analysis of cytokine expression in human osteoarthritis and healthy cartilage.J Rheumatol.1999,26(4):870-9.
1.沈冯君,刘日光,沈骏等.化瘀活骨汤治疗股骨头缺血坏死的实验研究.中国骨伤,2000;13(3):149-150.
2.姚永乐,王国毓,杨毓华,等.激素性股骨头坏死动物血液流变学的观察.中医正骨,2000;12(4):6-7.
3.张晓刚,任远,张剑峰,等.生骨再造散对激素性股骨头坏死模兔血液流变学的影响.中医正骨,2000,12(10);3-4.
4.陆裕朴,胥少汀,葛宝丰,等.实用骨科学.北京:人民军医出版社,1998,1074.
5.朱盛修.股骨头缺血性坏死诊疗.湖南科学技术出版社,1999,205.
6.赵炬才,张铁良.髋关节外科学.北京:中国医药科技出版社,1992,314-315.
7.刘昱,姜益常.补阳还五汤加减改善股骨头坏死病人血液粘度的临床研究.中医药学报,1996,1(1):32.
1. Mayer H, Bertram H, Lindenmaier W, et al. Vascular endothelial growth factor(VEGF-A)expression in human mesenchyreal stem cells: autocrine and paracrine role on osteoblastic and endothelial diferentiation[J]. J Cell Biochem, 2005, 195(4): 827-839
2. Geiger F, Bertram H, Berger I, et al. Vascular endothelial growth factor geue-activated matrix(VEGFI65-GAM)enhances osteogenesis and angiogenesis in large segmental bone defects[J]. J Bone MinerRes, 2005, 20(11): 2028-2035
3. Maes C, Carmeliet P, Moermans K, et al. Impaired angiogenesis and endoc hondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGFI64 and VEGF188[J]. Mechanisms of Development, 2000, 111(1-2): 61-73
4. Aldridge SE, Lennard TW, Williams JR, et al. Vascular endothelial growth factor receptors in～teoclast diferentiation and funetion[J]. Biochem Biophys Res Commun, 2005, 335(3) : 793798
5. Zelzer E, McLean W, Ng Ys, et n￡. Skeletal defects in VEGF (120/120)mice reveal multiple roles for VEGF in skeletogenesis [J]. Dm, 2002, 129(8): 1893-1904
6. Niida S, Kondo T, Hiratsuks, S, et al. VEGF receptor 1 sigmaling is essential for osteoclast development and bo ne marrow formation formation in cOlony-stimulating factor 1-deficient mice[J]. Proc Natl Acad Sci I/SA, 2005, 27; 102(39): 14016-14021
7. Kumta SM, Huang L, Cheng YY, et al. Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions[J]. ￡ Sciences, 2003, 73(11): 1427-1436
8. Matsumoto Y, Tanaka K, Hiram G, et al. Possible involvement ofthe vascular endothelial growth factor-Fit-1 -focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints[J]. J Immunol, 2002, 168(11): 5824-5831
1.Resnick D.Diagnosis of Bone and Joint Disorders.4th ed.北京:人民卫生出版社,2002:1269-1271.
2.邵俊杰.细胞因子与骨关节炎.国外医学:骨科学分册,2001,3:143-146.
3.FelsonDT,Zhang YQ,MariianT,et al.Risk factors for incident radiographic knee osteoarthritis in elderly;the Framingham STUDY J.Arthritis Rheum,1997,40(4):728-733.
4.Cushnaghan J,Dieppe P.Study of 500 patients with limb joint osteoarthritis.I.Analysis by age,sex,and distribution of symptomatic joint sites.Ann Rheum Dis 1991;50(1):8-13
5.Adebajo AO.Pattern of osteoarthritis in a West African teaching hospital.Ann Rheum Dis 1991;50(1):20-2
6.Silman AJ,Hochberg MC.Osteoarthritis//Silman AJ,Hochberg MC,eds.Epidemiology of the rheumatic disease.Oxford Univ Press 1993:257
7.中华医学会骨科学分会,骨关节炎诊治指南(2007年版).中国临床医生杂志,2008,36(1):29-30.
8.Wollheim FA.Early stages of osteoarthritis:the search for sensitive predictors.Ann Rheum Dis,2003,62(11):1031-1032
9.肖征宇.骨性关节炎临床研究进展.新医学,2007,38(1):4-6.
10.丁小南,袁建华,李杰,等.腰椎小关节退变的CT诊断(附100例分析).实用医学影像杂志,2002,3(1):20-22.
11.McNally EG.Magnetic resonance imaging of the knee[J].BMJ,2002,325(7356):115-116
12.Horii M,Kubo T,Hirasawa Y.Radial MRI of the hip with moderate osteoarthritis[J].J Bone Joint Surg Br,2000,82(3):364-368.
13.马立恒.关节软骨的结构与生物力学的关系及MRI成像.国外医学:临床放射学分 册,2006,29(2):123-126.
14.庄承成,肖萤,廖锦堂,等.骨性关节炎关节软骨的超声诊断与评估.中华医师杂志,2005,7(1):51-53.
15.Aisen AM,McCune WJ,MacGuire A,et al.Sonographic evalution of the cartilage of the knee[J].Radiology,1984,153(1):781-784
16.Lorig K,Kraines RG.Holman HR.A randomized prospective study of the effects of health education for people with arthritis.Arhtritis Rheum.1981,24(suppl 4):90.
17.Lorig K,Holman HR.Long term outcomes of an arthritis self-management study:effects of reinforcement efforts.Soc Sci Med.1984,29(1):2221-224.
18.Lorig K,Mazonson P,Holman HR.Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs.Arthritis Rheum.1993,36(1):439-446.
19.Lorig K,Seleznick M,Lubeck D,et al.The beneficial outcomes of the arthritis self-management course are inadequately explained by behavior change.Arthritis Rheum.1989,32(1):91-95.
20.涂杨茂,张朝驹.中医辨证治疗膝关节骨性关节炎.中医中药,2006,3(26):113.
21.邬亚军,赵治友,何永生.中药治疗膝关节骨关节炎的临床观察.四川中医,2006,24(6):80-81.
22.任树军,石文军,王东军.针灸配合中药内服外洗治疗膝骨性关节炎.中医正骨,2006,18(4):25-26.
23.罗世东,黄有荣.中医治疗膝关节骨性关节炎概况.广西中医药大学学报,2007,10(3):91-94.
24.姜洪洋,薛剑冰,程云峰.中药熏洗治疗膝关节骨性关节炎120例报告.中医正骨,2004,16(7):50.
25.王建国,何丽娟.温针灸治疗膝骨关节炎疗效观察.中图针灸,2007,27(3):191-192.
26.孙学东.“围刺”治疗膝关节增生性骨关节病86例.北京中医,1998,17(2):42.
27.姚家马录,宋亚文,张伟.轻手法按摩膝周滑囊治疗膝骨性关节炎.中医正骨,2006,18(3):212.
28.董良.手法配合中药治疗原发性膝关节骨性关节炎30例.中医研究,2006,19(8):55-56.
29.戴七一.手法对兔膝骨性关节炎软骨细胞DNA氧化性损伤的防治作用.中医正骨,2006,18(3):166-167.
30.曹光裕,刘献祥.四步推拿法治疗膝骨性关节炎90例报告.中医正骨,2006,18(4):23.
31.米永昌,宋朝辉,李正义小针刀加关节腔注射透明质酸钠治疗膝关节骨关节炎.河南外科学杂志,2006,12(1):47.
32.高楠,秦斌,任婷婷.针刀配合施沛特治疗膝骨性关节炎疗效观察.中医正骨,2007,19(2):16-18.
33.陈文治,葛鸿庆,王君鳌,等.关节腔注射参麦液治疗膝关节骨性关节炎的临床疗效观察.天津中医药,2005,22(6):518.
34.杨惠琴,陈礼荣.骨性关节炎的诊治新进展.临床内科杂志,2006,23(10):659-661.
35.Smith WL.Prostanoid biosynthesis and mechanism of action.Am J Physiol,1992,263(1):181-191.
36.JanMagnusBjordal,AnneElisabeth Ljunggren,AtleKlovning,et al.Non-steroidal anti-inflammatory drugs,including cyclo-oxygenase-2 inhibitors,in osteoarthritic knee pain:meta-analysisofrandomised placebo controlled trial.Am J Physiol,2005,155(3):91-93.
37.邓渝林,陶霞,周静,等.第二代COX-2抑制剂的研究进展.解放军药学学报,2006,21(3):209-304.
38.沈金芳,徐彬.新环氧酶—2抑制剂etoricoxib.世界临床药物,2004,25(3)182-186.
39.解皓,李海涛.非菌体类抗炎药不良反应的再认识及其防治.河北医药,2004,26(1):40-42.
40.Schnitzer TJ.Non-NSAID pharmacologic treatment options for the management of chronic pain.Am J Med.1998,105(1):45-52.
41.Roth SH.Efficacy and safety of tramadol HCL in breakthrough musculoskeletal pain attributed to osteoarthritis.J Rheumatol.1998,27(1):1358-1363.
42.Katz WA.pharmacology and clinical experience with tramadol in osteoarthritis.Drugs,1996,52(suppl 3):39-47.
43.Aronson MD.Nonsteroidal anti-inflammantory drugs,traditional opioids,and tramadol:contrasting therapies for the treatment of chronic pain.Clin Ther discussion,1997,19(3):367-368.
44.Schnitzer TJ,Kamin M,Olson WH.Tramadol allows reduction of naproxen dose among patients with naproxen-resposive osteoarthritis pain:a randomized,double blind,placebo controlled trial,Arhtritis Rheum,1999,42(1):1370-1377.
45.张光健.骨关节炎的非手术治疗,国外医学·骨科学分册.2004,56(3)239-240.
46.Frisbie DD,Mc wraith CW.Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis.Clin Orthop,2000,379(Suppl):273-287.
47.金翠英,芮耀城.现代药物学.北京:人民军医出版社,1999.438-468.
48.吴在德.外科学(第六版).北京:人民卫生出版社,911.
49.Brandt KD,Smith GN,Simon LS Jr.Intraarticular injection of byaluronan as treatment for knee osteoarthritis.Arthritis Rheum,2000,43(6):1192-203.
50.Caborn D,Rush J,Lanzer W,et al.A randomized,single-blind compairson of the efficacy and tolerability of hylan G-20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee.J Rheum,2004,31(2):333-43.
51.Homandberg GA,Ummadi V,Kang H.High molecular weight byaluronan promotes repair of IL-1β-damaged cartilage explants from both young and old bovines[J]Osteoarthritis Cart,2003,11(3):177-86.
52.汤志辉,沈宏达,张俊,王良勇透明质酸钠(施沛特)在踝关节骨性关节炎治疗中的应用.临床骨科杂志,2007,10(4):381-382.
53.高宛英,孙太存.中国现代应用药学杂志.2005,22(6):507-508.
54.陈海鹏,林成聪,柯继敏.透明质酸钠治疗膝关节骨性关节炎临床观察.中医正骨,2005,17(4):14-15.
55.王俊文,李锋,勘武生,等.透明质酸钠治疗膝骨性关节炎的疗效分析.临床外科杂志,2006,14(6):376-378.
56.Balazs EA,Denlinger JL.Viscosupplementation:a new concept in the treatment of osteoarthritis.J Rheumatol Suppl,1993,39(5):3-5.
57.Peyron JG,Hordon L,Bird HA,et al.Intraarticular hyaluronan in jections in the treatment of osteoarthritis:state of the artreview.J Rheumatol Suppl,1993,39(3):10-11.
58.陈维钓,郑维好,赵文志,等.透明质酸钠关节内注射治疗老年人骨性关节炎临床观察.中华老年医学杂志,1999,18(3):173.
59.张洪,欧阳侃.骨性关节炎的治疗进展.中国医学工程,2007,15(7):574-577.
60.穆国斌,阎景奎,赵家瑜,等.关节镜并胫骨高位截骨术对膝内翻骨性关节炎治疗体会.河北医药,2006,28(1):43-44.
61.苏伟.钻孔减压治疗骨性关节炎——附40例临床观察报告.医药世界,2008,12(1):85-86.
62.殷力,许建中,谭宏宇等.膝关节骨性关节炎的微创外科治疗.中原医刊,2006,33(20):50.
63.杨惠琴,陈礼荣.骨性关节炎的诊治新进展.临床内科杂志,2006,23(10):659-672.
64.蒋明,DAVID YU,林孝义,等.中华风湿病学.北京:华夏出版社,2004.1296-1297.
65.吴琼华,陈正形.基质金属蛋白酶与腰椎间盘病变.国外医学.骨科学分册,2002,23(1):93-95.
66.DD Frisbie,SC Ghivizzan,i PD Robbins,et a.l Treatment of esprimentaleqione osteaoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonistgene.Gene Ther,2002,9(1):12-20.
67.Chemajovsky Y,Adams G,Podhajcer C,et a.l Inhibition of transfer of collagen-induced arthritis into SCID mice by es vivo infection of spleen cellswith retroviruses expressing soluble tumornecrosis factor receptor.Gene Trer,1995,2(3):731-732.
68.Ikeda T,KuboT,AraiY,eta.l Adenovirusmediated genedelivery to the joints ofguinea pigs.JRheumato,l 1998,25(6):1666-1673.
69.KangR,MaruiT,GhivizzaniSC,eta.l Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects:A feasibility study.OsteoarthritisCartilage,1997,5(2):139-143.
70.Doherty PJ,ZhangH,ManolopoulosV,et a.l Adhesion of trandplanted chondrocytes onto cartilage in vitro and in vivo.JRheumato,l 2000,27(1):1725-1731.
71.OliginoT,Ghivzzani S,Wolfe D,et a.l Intra-articular delivery of a herpes simplex virus IL-1Ra gerne vector trduces inflammation in a rabbit model of arthritis.Gene Ther,1999,6(1):1713-1720.
72.Tomita T,HashimotoH,TomitaH eta.l In vivo directgene transfer into articular cartilage by intraariticular injectionmediated byHVJ(sendai) virus and liposomes.ArthritisRheum,1997,40(1):901-906
73.Frisbie DD,Mc.wraith CW.Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis.Clin Orthop,2000,379(Suppl):S273-S287.
74.Margulies JY,Payzer A,Nyska M.The relationship between degenerative changes and osteoporosis in the lumbar spine.Clin Orthop,1996,3(24):145.
75.Silver JJ,Einhorn TA.Osteoporosis and aging.Clin Orthop,1995,316(1):10-20.
76.MallucheHH,FaugereMC,DorrLD.Systemic changes in bone structure and bone formation in patients with osteoarthritis(OA).Trans Orthop Res Soc,1983,8(4):139.
77.Masud T,Langley S,Wiltshire P,et al.Effect of spinal osteophytosis on bone mineral density measurement in vertebral osteoporosis.Br Med J,1993,307(1):172.
78.黄火高,郑毅,尹义存.骨性关节炎的定量超声骨密度研究.天津医药,2004,32(12):737-739.
79.周乙雄,姚力,薛延,等.中老年女性骨关节炎患者骨密度的特点.中国骨质疏松杂 志,2002,8(3):219-221.
80.丁仁奎,孙材江,王万春,等.膝关节退行性骨关节病与骨质疏松的相关关系研究.湖南医学,1997,14(6):323.
81.KENNEDY AC,MULLER BJ,ROTH SH.Current Therapeutic Research[J].Clinical&Experimental,2000,55(2):119-132.
82.HURLEY M V.Muscle,exercise and arthritis[J].Annals of the Rheumatic Diseases,2002,16(8):673- 675.
83.HULME J,ROBINSON V,DEBIE R,et al.The Cochrame Databas of Systematic Reviews,2002,4.
84.NICOLAKIS P,KOLLMITZER J,CREVENNA R,et al.Pulsed magnetic field therapy for osteoarthritis of the knee--a double- blind sham- controlled trial[J].Wien Klin Wochenschr,2002,114(15-16):678-684.
1.刘林英.股骨头坏死分析.中国疗养医学.2007,16(7):447.
2.王凤仪,马在山,马素英等.山东中部地区人群股骨头坏死流行病学调查研究.中国骨伤.2001,14(6):345-346.
3.高广凌,王亮,黄相杰.股骨头坏死误诊27例分析.中国误诊学杂志.2007,7(24):5813-5814.
4.张旭,王衡.早期股骨头缺血性坏死误诊原因分析.医药论坛杂志.2007,28(13):33-34.
5.谢大成.102例股骨头无菌性坏死的病因分析.中国保健.2007,15(17):38.
6.王学谦,李秀兰,师宜健,等.甲基强的松龙冲击疗法引发股骨头缺血性坏死的实验研究.2007,27(11):849-854.
7.袁洁.692例股骨头缺血性坏死病因调查分析,广州中医药学院院报,1994,11(1):29.
8.Ohzono K,Saito M,Takaoka K.Natural history of nontraumatic avascular necrosis of the femoral head.J Bone Joint Surg Br.1991,73(1):68-72.
9.李盛华,姚正凯.激素性股骨头坏死细胞凋亡的实验研究进展.甘肃中医.2007,20(9):61-62.
10.田刚,王大伟.酒精性股骨头缺血性坏死发病机制的研究近况.辽宁中医学院学报.2005,7(6):570-571.
11.Xiong M,Wang K,Dang X.An experimental study on osteocyte apoptosis in steroid-induced early osteonecrosis of femoral head.Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi,2007,21:262-265.
12.Bartonicek J,Fric V,Skala-Rosenbaum J,Dousa P.Avascular necrosis of the femoral head in pertrochanteric fractures:a report of 8 cases and a review of the literature.J Orthop Trauma.2007,21(4):229-36.
13.Kerachian MA,Harvey EJ,Cournoyer D.Avascular necrosis of the femoral head: vascular hypotheses.Journal of Endothelium cell research.2006,13(4):237-44.
14.杨山林,马国良,王玉民.51例老年股骨头无菌性坏死患者的影像学结果分析.中国现代医生.2007,45(14):82.
15.胡雪芹,周琳,高冬梅.成人股骨头缺血坏死的临床与影像诊断.海南医学.2007.18(11):163-164.
16.崔安明.低场MRI对股骨头缺血坏死的诊断价值.中国实用医药.2007.2(28):42-43.
17.王代兵,李晖.股骨头缺血坏死80例X线,CT诊断分析.中国误诊学杂志.2007,7(17):3999.
18.孟义兴,周鹏,高雪梅.股骨头缺血坏死的影像学改变及其诊断价值.中国临床实用医学.2007,1(9):34-37.
19.秦光秀,彭巧勤.股骨头缺血性坏死的CT诊断.现代医药卫生.2007,23(17):2626-2627.
20.郑洪民,王晖,李桂雪.核磁共振成像在股骨头缺血性坏死中诊断应用的探讨.中国现代医生.2007,48(12):80-81.
21.邱郦,苏白海,罗燕.股骨头缺血性坏死的超声表现及其临床意义.中国医学影像技术.2007,23(11):1697-1699.
22.Mont MA,Hungerfrord DS,Maryland B.Current concepts re-view non-traumatic avascular necrosis of the femoral head.J Bone Joint Surg,1995,77(1):459.
23.Pritchet JW.Statin therapy decreases the risk of osteonecrosis inpatiens receiving steroids.Clin Orthop,2001,386(3):173-178.
24.李卫哲,李景南,张新,等.抗凝药物预防激素所致股骨头坏死.吉林大学学报(医学版),2003,29(4):475-476.
25.StembergME,HaykenG D,StembergD R,et al.Aguantatine system for staging avascular necrosis.J BoneJoint surg Br,1995,77:34.
26.陈卓明,程秀萍,张岷波,等.高压低频脉冲电流治疗股骨头缺血性坏死临床研究.中国疗养医学,2002,11(2):10.
27.韩永台,未立新,李欣,等.分米波治疗股骨头缺血性坏死.中华理疗杂志,1999,22(2): 72.
28.Wang CJ,Wang FS,Huang CC,et al.Treatment for osteonecro-sis the femoral head:comparison of extracorposreal shock waveswith core decompression and bone-grafting.J Bone Joint SurgBr,2005,87(1):2380-2387.
29.Reis N D,Schwartz O D,Milinnu D,et al.Hypebaricoxygen therapy as treatment for stage-Ⅰ avacular necrosisof the femoral head.J Bone Joint surg Br,2003,85(1):371-375.
30.孔霞,孔爱兰.高压氧加局部热敷治疗股骨头坏死3例报道.中国热带医学,2003,3(4):496.
31.胡国辉,惠小平,陆一鸣.高压氧治疗股骨头坏死79例的疗效观察.上海医学,2002,25(12):783.
32.王建华,陈立波,张长青,等.中国人血管生成素-1cDNA克隆和序列分析.中华实验外科杂志,2003,20(5):411-412.
33.杨晓凤,王红梅,许忆峰,等.经动脉骨髓干细胞移植治疗股骨头坏死63例.中国临床康复,2006,10(13):3-5.
34.常炳营,刘亚,田云虎,等.髓芯减压植骨联合BMP植入治疗股骨头坏死的临床观察.潍坊医学院学报,2006,22(1):5-7.
35.李杨,王福剑,曹锡文,等.儿童创伤性股骨头坏死的综合治疗.中国现代药物应用.2007,1(8):15-17.
36.Sternberg ME,Larcom PG,Strafford B,et al.Core decompres-sion withbone grafting for osteonecrosis of the femoral head.Clin Orthop,2001,386(5):71-78.
37.陈峰,肖增明.髓芯减压治疗股骨头缺血性坏死的研究进展[J].医学综述,2006,12(15):925-927.
38.孙永强,程少丹,张国永.非创伤性股骨头坏死临床常用治疗方法分析.中国误诊学杂志.2007,7(24):5794-5796.
39.Leung PC.Femoral head reconstruction and revascularizationtreatment for ischemic necrosis.Clin Orthop,1996,323(1):139-145.
40.张长青,曾炳芳,日圭述平,等.改良吻合血管游离腓骨移植治疗股骨头缺血性坏死的手术技术.中国修复重建外科杂志,2005,9(9):692-696.
41.Scheider W,Aigner N,Pinggera O,et al.lntertrochanteric os-teotomy for vascular necrosis of the femoral head of the femur,survival probability of two different methods.Bone JointSurg(Br),2002,84(1):817-825.
42.Mont MA,Rajadhyaksha AD,Hungerford DS.Outcomes of limited femoral resurfacing arthroplasty compared with hip ar-throplasty for osteonecrosis of the femoral head.J Arthro-plasty,2001,16(1):134-141.
43.肖增明,詹新立,李世德,等.精确匹配的半髋表面置换术治疗股骨头缺血性坏死.中华外科杂志,2006,8(1):17-19.
44.杨述华,杨操,王锐英,等.空心钛支撑架结合自体骨移植治疗股骨头坏死.临床骨科杂志,2005,8(4):289-290.
45.王岩,王继芳,卢世壁,等.网球支架置入治疗成人股骨头缺血性坏死.中华骨科杂志,2000,20(5):295-298.
46.张彦,张长青.股骨头缺血性坏死病程发展及治疗中的生物力学因素.国外医学骨科学分册,2005,26(5):293-294.
47.王义生,殷力,吴学建,等.微创小切口人工全髋关节置换术治疗晚期股骨头坏死.中原医刊,2006,20(1):13-15.
48.Xenakis TA,Gelalis J,Koukoubis TA,et al.Cementless hip arthroplasty in the treatment of patients with femoral head nec-rosis.Clin Orthop,2001,386(5):93-99.
49.Fyda TM,Callaghan JJ,Olejniczak J,et al.Minimum ten-year followup of cemented total hip replacement in patients with os-teonecrosis of the femoral head.Iowa Orthop,2002,22(4):8-19.
50.何齐芳,尚希福.茶黄素抑制激素性股骨头坏死的实验研究.安徽医科大学学报.2007,42(2):415-419.
51.李桂文.四物强骨方治疗股骨头坏死临床疗效观察.广西中医药,2004,27(3):45.
52.臧新开,臧新亚.桂枝芍药知母汤加味治疗股骨头坏死.现代中西医结合杂志,2002, 11(17):1695.
53.刘维立,赵文海,王丹彤.股骨头缺血性坏死治疗常用中药及用药规律.吉林中医药.2007,27(9):53-54.
54.焦红波,刘海英,焦念学.针刺治疗股骨头坏死2例.中医外治杂志,2002,11(3):19.
55.崇桂文.髋三针治疗股骨头坏死的体会.中国针灸,1998,(7):439.
56.白良川,许冠芤,张荣军,等.电针对兔激素性股骨头坏死局部组织血流的影响.安徽中医学院学报.2004,23(1):3.
57.王炳.推拿治疗股骨头缺血性坏死的临床初步探索.按摩与导引.2007,23(7):32-34.
58.孙国辉,董晓俊,覃剑.中药配合小针刀治疗股骨头缺血性坏死的临床观察,中国中医骨伤科杂志.2007,15(10):42-43.
59.钟立清,孟庆云,王平均,等.激素引起股骨头无菌性坏死的介入治疗.淮海医药,2004,22(1):32.
60.韩松辉,郭树农,王锐,等.介入治疗非创伤股骨头缺血性坏死32例临床分析.河南科技大学学报(医学版),2003,21(3):172.
61.葛东泉,张爱珍,马登全,等.中西医结合治疗股骨头缺血性坏死的临床研究.现代中西医结合杂志,2000,9(23):2317.
62.孟广谦,陈永敏.综合疗法治疗股骨头缺血性坏死的研究.中国民族医药杂志.2007,8(9):14-15.
63.杨述华.骨坏死学.北京:人民卫生出版社,2002:7-8.
64.张智慧,昝强.股骨头坏死的非手术治疗进展.甘肃中医学院学报.2006,23(5):48-50.
2.Zhang,Y,Hunter DJ,Nevitt MC,et al.Association of squatting with increased prevalence of radiographic tibiofemoral knee osteoarthritis[J].Arthritis Rheum,2004(50):1187-1192.
3.邵俊杰.细胞因子与骨关节炎J.国外医学:骨科学分册,2001,3:143-146.
4.Jiang Q,Shi D,Yi L,et al.Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese.J Hum Genet.2006;51(12):1068-72.
5.Mustafa Z,Dowling B,Chapman,et al.Investigating the aspartic acid(D) repeat of asporin as a risk factor for osteoarthritis in a UK Caucasian population.Arthritis Rheum.2005 Nov;52(ll):3502-6.
6.Rodriguez-Lopez J,Pombo-Suarez M,Liz M,et al.Lack of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility:case-control studies in Spanish Caucasians.Arthritis Res Ther.2006;8(3):R55.
7.刘林英.股骨头坏死分析.中国疗养医学.2007,16(7):447.
8.王凤仪,马在山,马素英等.山东中部地区人群股骨头坏死流行病学调查研究.中国骨伤.2001,14(6):345-346.
9.高广凌,王亮,黄相杰.股骨头坏死误诊27例分析.中国误诊学杂志.2007,7(24):5813-5814.
10.张旭,王衡.早期股骨头缺血性坏死误诊原因分析.医药论坛杂志.2007,28(13):33-34.
11.谢大成.102例股骨头无菌性坏死的病因分析.中国保健.2007,15(17):38.
12.王学谦,李秀兰,师宜健等.甲基强的松龙冲击疗法引发股骨头缺血性坏死的实验研 究.2007,27(11):849-854.
13.袁洁.692例股骨头缺血性坏死病因调查分析,广州中医药学院院报,1994,11(1):29.
14.Ohzono K,Saito M,Takaoka K.Natural history of nontraumatic avascular necrosis of the femoral head.J Bone Joint Surg Br.1991,73(1):68-72.
15.李盛华,姚正凯.激素性股骨头坏死细胞凋亡的实验研究进展.甘肃中医.2007,20(9):61-62.
16.田刚,王大伟.酒精性股骨头缺血性坏死发病机制的研究近况.辽宁中医学院学报.2005,7(6):570-571.
17.Xiong M,Wang K,Dang X.An experimental study on osteocyte apoptosis in steroid-induced early osteonecrosis of femoral head.Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi,2007,21:262-265.
1.吴阶平,裘法祖主编,黄家驷外科学第六版北京:人民卫生出版社2131
2.张乃峥,施全胜,张雪哲,等.膝骨关节炎的流行病学调查.中华内科杂志,1995,34(2):84-87.
3.曾庆馀,黄少弼,肖征宇,等.症状性骨关节的临床和流行病学探讨.中华内科杂志,1995,34(1):88.
4.Spector TD,Hart DJ,Doyle DR et al.Incidence and progression of osteoarthritis in women with unilateral knee disease in the general population:the effect of ebesity.Ann Rheum Dis.1994:53(1):565.
5.叶永平.膝关节骨关节炎致病因素研究.国外医学·创伤与外科基本问题分册,1999,20(1):1-3.
6.路志正,焦树德主编,实用中医风湿病学北京:人民卫生出版社1996,608-619.
1.魏泉洁,蒋位庄,张晓铀.骨质疏松症与退行性骨关节病相关性实验研究.中国骨伤,1997,12(4):14-17.
2.Healey JH,Vigorita VJ,Lane JM.The coexistance and characteristics of osteoarthritis and osteoporosis.J Bone joint Sury,1985,67(1):586.
3.Hart DJ,Mootoosamy I,Doyle DV,et al.The relationship between osteoarthritis and osteoporosis in the general population:The Chinford Study.Ann Rheum Dis,1994,53(1),158.
4.王雪飞.骨关节炎与骨质疏松相关性研究.中国骨质疏松杂志,1999,5(3):73-76.
5.张银桃,唐建明,侯亚平.骨关节炎与骨质疏松症关系的研究.中国现代医学杂志,1996,6(3):9-10.
6.丁仁奎,孙材江,王万春.膝关节退行性骨关节病与骨质疏松的相关关系研究.湖南医学,1997,14(6):323-324.
7.戴力扬.脊柱骨关节炎与骨质疏松的关系.中国矫形外科杂志,1997,4(5):364-365.
8.Zheng SX,Vrindts Y,Lopez M,et al.Increase in cytokine production by stimulated whole blood cells in postmenopausal osteoporosis.Maturitas,1997,26(1):63.
9.Goldring,-m-b.The role of cytokines as inflammatory mediators in osteoarrthritis:lessons from animal models.Connect-Tissue-Res.1999,40(1):1-11.
10.Moos,-V;Fickert,-S;Muller,-B.Immunohistological analysis of cytokine expression in human osteoarthritis and healthy cartilage.J Rheumatol.1999,26(4):870-9.
1.沈冯君,刘日光,沈骏等.化瘀活骨汤治疗股骨头缺血坏死的实验研究.中国骨伤,2000;13(3):149-150.
2.姚永乐,王国毓,杨毓华,等.激素性股骨头坏死动物血液流变学的观察.中医正骨,2000;12(4):6-7.
3.张晓刚,任远,张剑峰,等.生骨再造散对激素性股骨头坏死模兔血液流变学的影响.中医正骨,2000,12(10);3-4.
4.陆裕朴,胥少汀,葛宝丰,等.实用骨科学.北京:人民军医出版社,1998,1074.
5.朱盛修.股骨头缺血性坏死诊疗.湖南科学技术出版社,1999,205.
6.赵炬才,张铁良.髋关节外科学.北京:中国医药科技出版社,1992,314-315.
7.刘昱,姜益常.补阳还五汤加减改善股骨头坏死病人血液粘度的临床研究.中医药学报,1996,1(1):32.
1. Mayer H, Bertram H, Lindenmaier W, et al. Vascular endothelial growth factor(VEGF-A)expression in human mesenchyreal stem cells: autocrine and paracrine role on osteoblastic and endothelial diferentiation[J]. J Cell Biochem, 2005, 195(4): 827-839
2. Geiger F, Bertram H, Berger I, et al. Vascular endothelial growth factor geue-activated matrix(VEGFI65-GAM)enhances osteogenesis and angiogenesis in large segmental bone defects[J]. J Bone MinerRes, 2005, 20(11): 2028-2035
3. Maes C, Carmeliet P, Moermans K, et al. Impaired angiogenesis and endoc hondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGFI64 and VEGF188[J]. Mechanisms of Development, 2000, 111(1-2): 61-73
4. Aldridge SE, Lennard TW, Williams JR, et al. Vascular endothelial growth factor receptors in～teoclast diferentiation and funetion[J]. Biochem Biophys Res Commun, 2005, 335(3) : 793798
5. Zelzer E, McLean W, Ng Ys, et n￡. Skeletal defects in VEGF (120/120)mice reveal multiple roles for VEGF in skeletogenesis [J]. Dm, 2002, 129(8): 1893-1904
6. Niida S, Kondo T, Hiratsuks, S, et al. VEGF receptor 1 sigmaling is essential for osteoclast development and bo ne marrow formation formation in cOlony-stimulating factor 1-deficient mice[J]. Proc Natl Acad Sci I/SA, 2005, 27; 102(39): 14016-14021
7. Kumta SM, Huang L, Cheng YY, et al. Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions[J]. ￡ Sciences, 2003, 73(11): 1427-1436
8. Matsumoto Y, Tanaka K, Hiram G, et al. Possible involvement ofthe vascular endothelial growth factor-Fit-1 -focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints[J]. J Immunol, 2002, 168(11): 5824-5831
1.Resnick D.Diagnosis of Bone and Joint Disorders.4th ed.北京:人民卫生出版社,2002:1269-1271.
2.邵俊杰.细胞因子与骨关节炎.国外医学:骨科学分册,2001,3:143-146.
3.FelsonDT,Zhang YQ,MariianT,et al.Risk factors for incident radiographic knee osteoarthritis in elderly;the Framingham STUDY J.Arthritis Rheum,1997,40(4):728-733.
4.Cushnaghan J,Dieppe P.Study of 500 patients with limb joint osteoarthritis.I.Analysis by age,sex,and distribution of symptomatic joint sites.Ann Rheum Dis 1991;50(1):8-13
5.Adebajo AO.Pattern of osteoarthritis in a West African teaching hospital.Ann Rheum Dis 1991;50(1):20-2
6.Silman AJ,Hochberg MC.Osteoarthritis//Silman AJ,Hochberg MC,eds.Epidemiology of the rheumatic disease.Oxford Univ Press 1993:257
7.中华医学会骨科学分会,骨关节炎诊治指南(2007年版).中国临床医生杂志,2008,36(1):29-30.
8.Wollheim FA.Early stages of osteoarthritis:the search for sensitive predictors.Ann Rheum Dis,2003,62(11):1031-1032
9.肖征宇.骨性关节炎临床研究进展.新医学,2007,38(1):4-6.
10.丁小南,袁建华,李杰,等.腰椎小关节退变的CT诊断(附100例分析).实用医学影像杂志,2002,3(1):20-22.
11.McNally EG.Magnetic resonance imaging of the knee[J].BMJ,2002,325(7356):115-116
12.Horii M,Kubo T,Hirasawa Y.Radial MRI of the hip with moderate osteoarthritis[J].J Bone Joint Surg Br,2000,82(3):364-368.
13.马立恒.关节软骨的结构与生物力学的关系及MRI成像.国外医学:临床放射学分 册,2006,29(2):123-126.
14.庄承成,肖萤,廖锦堂,等.骨性关节炎关节软骨的超声诊断与评估.中华医师杂志,2005,7(1):51-53.
15.Aisen AM,McCune WJ,MacGuire A,et al.Sonographic evalution of the cartilage of the knee[J].Radiology,1984,153(1):781-784
16.Lorig K,Kraines RG.Holman HR.A randomized prospective study of the effects of health education for people with arthritis.Arhtritis Rheum.1981,24(suppl 4):90.
17.Lorig K,Holman HR.Long term outcomes of an arthritis self-management study:effects of reinforcement efforts.Soc Sci Med.1984,29(1):2221-224.
18.Lorig K,Mazonson P,Holman HR.Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs.Arthritis Rheum.1993,36(1):439-446.
19.Lorig K,Seleznick M,Lubeck D,et al.The beneficial outcomes of the arthritis self-management course are inadequately explained by behavior change.Arthritis Rheum.1989,32(1):91-95.
20.涂杨茂,张朝驹.中医辨证治疗膝关节骨性关节炎.中医中药,2006,3(26):113.
21.邬亚军,赵治友,何永生.中药治疗膝关节骨关节炎的临床观察.四川中医,2006,24(6):80-81.
22.任树军,石文军,王东军.针灸配合中药内服外洗治疗膝骨性关节炎.中医正骨,2006,18(4):25-26.
23.罗世东,黄有荣.中医治疗膝关节骨性关节炎概况.广西中医药大学学报,2007,10(3):91-94.
24.姜洪洋,薛剑冰,程云峰.中药熏洗治疗膝关节骨性关节炎120例报告.中医正骨,2004,16(7):50.
25.王建国,何丽娟.温针灸治疗膝骨关节炎疗效观察.中图针灸,2007,27(3):191-192.
26.孙学东.“围刺”治疗膝关节增生性骨关节病86例.北京中医,1998,17(2):42.
27.姚家马录,宋亚文,张伟.轻手法按摩膝周滑囊治疗膝骨性关节炎.中医正骨,2006,18(3):212.
28.董良.手法配合中药治疗原发性膝关节骨性关节炎30例.中医研究,2006,19(8):55-56.
29.戴七一.手法对兔膝骨性关节炎软骨细胞DNA氧化性损伤的防治作用.中医正骨,2006,18(3):166-167.
30.曹光裕,刘献祥.四步推拿法治疗膝骨性关节炎90例报告.中医正骨,2006,18(4):23.
31.米永昌,宋朝辉,李正义小针刀加关节腔注射透明质酸钠治疗膝关节骨关节炎.河南外科学杂志,2006,12(1):47.
32.高楠,秦斌,任婷婷.针刀配合施沛特治疗膝骨性关节炎疗效观察.中医正骨,2007,19(2):16-18.
33.陈文治,葛鸿庆,王君鳌,等.关节腔注射参麦液治疗膝关节骨性关节炎的临床疗效观察.天津中医药,2005,22(6):518.
34.杨惠琴,陈礼荣.骨性关节炎的诊治新进展.临床内科杂志,2006,23(10):659-661.
35.Smith WL.Prostanoid biosynthesis and mechanism of action.Am J Physiol,1992,263(1):181-191.
36.JanMagnusBjordal,AnneElisabeth Ljunggren,AtleKlovning,et al.Non-steroidal anti-inflammatory drugs,including cyclo-oxygenase-2 inhibitors,in osteoarthritic knee pain:meta-analysisofrandomised placebo controlled trial.Am J Physiol,2005,155(3):91-93.
37.邓渝林,陶霞,周静,等.第二代COX-2抑制剂的研究进展.解放军药学学报,2006,21(3):209-304.
38.沈金芳,徐彬.新环氧酶—2抑制剂etoricoxib.世界临床药物,2004,25(3)182-186.
39.解皓,李海涛.非菌体类抗炎药不良反应的再认识及其防治.河北医药,2004,26(1):40-42.
40.Schnitzer TJ.Non-NSAID pharmacologic treatment options for the management of chronic pain.Am J Med.1998,105(1):45-52.
41.Roth SH.Efficacy and safety of tramadol HCL in breakthrough musculoskeletal pain attributed to osteoarthritis.J Rheumatol.1998,27(1):1358-1363.
42.Katz WA.pharmacology and clinical experience with tramadol in osteoarthritis.Drugs,1996,52(suppl 3):39-47.
43.Aronson MD.Nonsteroidal anti-inflammantory drugs,traditional opioids,and tramadol:contrasting therapies for the treatment of chronic pain.Clin Ther discussion,1997,19(3):367-368.
44.Schnitzer TJ,Kamin M,Olson WH.Tramadol allows reduction of naproxen dose among patients with naproxen-resposive osteoarthritis pain:a randomized,double blind,placebo controlled trial,Arhtritis Rheum,1999,42(1):1370-1377.
45.张光健.骨关节炎的非手术治疗,国外医学·骨科学分册.2004,56(3)239-240.
46.Frisbie DD,Mc wraith CW.Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis.Clin Orthop,2000,379(Suppl):273-287.
47.金翠英,芮耀城.现代药物学.北京:人民军医出版社,1999.438-468.
48.吴在德.外科学(第六版).北京:人民卫生出版社,911.
49.Brandt KD,Smith GN,Simon LS Jr.Intraarticular injection of byaluronan as treatment for knee osteoarthritis.Arthritis Rheum,2000,43(6):1192-203.
50.Caborn D,Rush J,Lanzer W,et al.A randomized,single-blind compairson of the efficacy and tolerability of hylan G-20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee.J Rheum,2004,31(2):333-43.
51.Homandberg GA,Ummadi V,Kang H.High molecular weight byaluronan promotes repair of IL-1β-damaged cartilage explants from both young and old bovines[J]Osteoarthritis Cart,2003,11(3):177-86.
52.汤志辉,沈宏达,张俊,王良勇透明质酸钠(施沛特)在踝关节骨性关节炎治疗中的应用.临床骨科杂志,2007,10(4):381-382.
53.高宛英,孙太存.中国现代应用药学杂志.2005,22(6):507-508.
54.陈海鹏,林成聪,柯继敏.透明质酸钠治疗膝关节骨性关节炎临床观察.中医正骨,2005,17(4):14-15.
55.王俊文,李锋,勘武生,等.透明质酸钠治疗膝骨性关节炎的疗效分析.临床外科杂志,2006,14(6):376-378.
56.Balazs EA,Denlinger JL.Viscosupplementation:a new concept in the treatment of osteoarthritis.J Rheumatol Suppl,1993,39(5):3-5.
57.Peyron JG,Hordon L,Bird HA,et al.Intraarticular hyaluronan in jections in the treatment of osteoarthritis:state of the artreview.J Rheumatol Suppl,1993,39(3):10-11.
58.陈维钓,郑维好,赵文志,等.透明质酸钠关节内注射治疗老年人骨性关节炎临床观察.中华老年医学杂志,1999,18(3):173.
59.张洪,欧阳侃.骨性关节炎的治疗进展.中国医学工程,2007,15(7):574-577.
60.穆国斌,阎景奎,赵家瑜,等.关节镜并胫骨高位截骨术对膝内翻骨性关节炎治疗体会.河北医药,2006,28(1):43-44.
61.苏伟.钻孔减压治疗骨性关节炎——附40例临床观察报告.医药世界,2008,12(1):85-86.
62.殷力,许建中,谭宏宇等.膝关节骨性关节炎的微创外科治疗.中原医刊,2006,33(20):50.
63.杨惠琴,陈礼荣.骨性关节炎的诊治新进展.临床内科杂志,2006,23(10):659-672.
64.蒋明,DAVID YU,林孝义,等.中华风湿病学.北京:华夏出版社,2004.1296-1297.
65.吴琼华,陈正形.基质金属蛋白酶与腰椎间盘病变.国外医学.骨科学分册,2002,23(1):93-95.
66.DD Frisbie,SC Ghivizzan,i PD Robbins,et a.l Treatment of esprimentaleqione osteaoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonistgene.Gene Ther,2002,9(1):12-20.
67.Chemajovsky Y,Adams G,Podhajcer C,et a.l Inhibition of transfer of collagen-induced arthritis into SCID mice by es vivo infection of spleen cellswith retroviruses expressing soluble tumornecrosis factor receptor.Gene Trer,1995,2(3):731-732.
68.Ikeda T,KuboT,AraiY,eta.l Adenovirusmediated genedelivery to the joints ofguinea pigs.JRheumato,l 1998,25(6):1666-1673.
69.KangR,MaruiT,GhivizzaniSC,eta.l Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects:A feasibility study.OsteoarthritisCartilage,1997,5(2):139-143.
70.Doherty PJ,ZhangH,ManolopoulosV,et a.l Adhesion of trandplanted chondrocytes onto cartilage in vitro and in vivo.JRheumato,l 2000,27(1):1725-1731.
71.OliginoT,Ghivzzani S,Wolfe D,et a.l Intra-articular delivery of a herpes simplex virus IL-1Ra gerne vector trduces inflammation in a rabbit model of arthritis.Gene Ther,1999,6(1):1713-1720.
72.Tomita T,HashimotoH,TomitaH eta.l In vivo directgene transfer into articular cartilage by intraariticular injectionmediated byHVJ(sendai) virus and liposomes.ArthritisRheum,1997,40(1):901-906
73.Frisbie DD,Mc.wraith CW.Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis.Clin Orthop,2000,379(Suppl):S273-S287.
74.Margulies JY,Payzer A,Nyska M.The relationship between degenerative changes and osteoporosis in the lumbar spine.Clin Orthop,1996,3(24):145.
75.Silver JJ,Einhorn TA.Osteoporosis and aging.Clin Orthop,1995,316(1):10-20.
76.MallucheHH,FaugereMC,DorrLD.Systemic changes in bone structure and bone formation in patients with osteoarthritis(OA).Trans Orthop Res Soc,1983,8(4):139.
77.Masud T,Langley S,Wiltshire P,et al.Effect of spinal osteophytosis on bone mineral density measurement in vertebral osteoporosis.Br Med J,1993,307(1):172.
78.黄火高,郑毅,尹义存.骨性关节炎的定量超声骨密度研究.天津医药,2004,32(12):737-739.
79.周乙雄,姚力,薛延,等.中老年女性骨关节炎患者骨密度的特点.中国骨质疏松杂 志,2002,8(3):219-221.
80.丁仁奎,孙材江,王万春,等.膝关节退行性骨关节病与骨质疏松的相关关系研究.湖南医学,1997,14(6):323.
81.KENNEDY AC,MULLER BJ,ROTH SH.Current Therapeutic Research[J].Clinical&Experimental,2000,55(2):119-132.
82.HURLEY M V.Muscle,exercise and arthritis[J].Annals of the Rheumatic Diseases,2002,16(8):673- 675.
83.HULME J,ROBINSON V,DEBIE R,et al.The Cochrame Databas of Systematic Reviews,2002,4.
84.NICOLAKIS P,KOLLMITZER J,CREVENNA R,et al.Pulsed magnetic field therapy for osteoarthritis of the knee--a double- blind sham- controlled trial[J].Wien Klin Wochenschr,2002,114(15-16):678-684.
1.刘林英.股骨头坏死分析.中国疗养医学.2007,16(7):447.
2.王凤仪,马在山,马素英等.山东中部地区人群股骨头坏死流行病学调查研究.中国骨伤.2001,14(6):345-346.
3.高广凌,王亮,黄相杰.股骨头坏死误诊27例分析.中国误诊学杂志.2007,7(24):5813-5814.
4.张旭,王衡.早期股骨头缺血性坏死误诊原因分析.医药论坛杂志.2007,28(13):33-34.
5.谢大成.102例股骨头无菌性坏死的病因分析.中国保健.2007,15(17):38.
6.王学谦,李秀兰,师宜健,等.甲基强的松龙冲击疗法引发股骨头缺血性坏死的实验研究.2007,27(11):849-854.
7.袁洁.692例股骨头缺血性坏死病因调查分析,广州中医药学院院报,1994,11(1):29.
8.Ohzono K,Saito M,Takaoka K.Natural history of nontraumatic avascular necrosis of the femoral head.J Bone Joint Surg Br.1991,73(1):68-72.
9.李盛华,姚正凯.激素性股骨头坏死细胞凋亡的实验研究进展.甘肃中医.2007,20(9):61-62.
10.田刚,王大伟.酒精性股骨头缺血性坏死发病机制的研究近况.辽宁中医学院学报.2005,7(6):570-571.
11.Xiong M,Wang K,Dang X.An experimental study on osteocyte apoptosis in steroid-induced early osteonecrosis of femoral head.Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi,2007,21:262-265.
12.Bartonicek J,Fric V,Skala-Rosenbaum J,Dousa P.Avascular necrosis of the femoral head in pertrochanteric fractures:a report of 8 cases and a review of the literature.J Orthop Trauma.2007,21(4):229-36.
13.Kerachian MA,Harvey EJ,Cournoyer D.Avascular necrosis of the femoral head: vascular hypotheses.Journal of Endothelium cell research.2006,13(4):237-44.
14.杨山林,马国良,王玉民.51例老年股骨头无菌性坏死患者的影像学结果分析.中国现代医生.2007,45(14):82.
15.胡雪芹,周琳,高冬梅.成人股骨头缺血坏死的临床与影像诊断.海南医学.2007.18(11):163-164.
16.崔安明.低场MRI对股骨头缺血坏死的诊断价值.中国实用医药.2007.2(28):42-43.
17.王代兵,李晖.股骨头缺血坏死80例X线,CT诊断分析.中国误诊学杂志.2007,7(17):3999.
18.孟义兴,周鹏,高雪梅.股骨头缺血坏死的影像学改变及其诊断价值.中国临床实用医学.2007,1(9):34-37.
19.秦光秀,彭巧勤.股骨头缺血性坏死的CT诊断.现代医药卫生.2007,23(17):2626-2627.
20.郑洪民,王晖,李桂雪.核磁共振成像在股骨头缺血性坏死中诊断应用的探讨.中国现代医生.2007,48(12):80-81.
21.邱郦,苏白海,罗燕.股骨头缺血性坏死的超声表现及其临床意义.中国医学影像技术.2007,23(11):1697-1699.
22.Mont MA,Hungerfrord DS,Maryland B.Current concepts re-view non-traumatic avascular necrosis of the femoral head.J Bone Joint Surg,1995,77(1):459.
23.Pritchet JW.Statin therapy decreases the risk of osteonecrosis inpatiens receiving steroids.Clin Orthop,2001,386(3):173-178.
24.李卫哲,李景南,张新,等.抗凝药物预防激素所致股骨头坏死.吉林大学学报(医学版),2003,29(4):475-476.
25.StembergME,HaykenG D,StembergD R,et al.Aguantatine system for staging avascular necrosis.J BoneJoint surg Br,1995,77:34.
26.陈卓明,程秀萍,张岷波,等.高压低频脉冲电流治疗股骨头缺血性坏死临床研究.中国疗养医学,2002,11(2):10.
27.韩永台,未立新,李欣,等.分米波治疗股骨头缺血性坏死.中华理疗杂志,1999,22(2): 72.
28.Wang CJ,Wang FS,Huang CC,et al.Treatment for osteonecro-sis the femoral head:comparison of extracorposreal shock waveswith core decompression and bone-grafting.J Bone Joint SurgBr,2005,87(1):2380-2387.
29.Reis N D,Schwartz O D,Milinnu D,et al.Hypebaricoxygen therapy as treatment for stage-Ⅰ avacular necrosisof the femoral head.J Bone Joint surg Br,2003,85(1):371-375.
30.孔霞,孔爱兰.高压氧加局部热敷治疗股骨头坏死3例报道.中国热带医学,2003,3(4):496.
31.胡国辉,惠小平,陆一鸣.高压氧治疗股骨头坏死79例的疗效观察.上海医学,2002,25(12):783.
32.王建华,陈立波,张长青,等.中国人血管生成素-1cDNA克隆和序列分析.中华实验外科杂志,2003,20(5):411-412.
33.杨晓凤,王红梅,许忆峰,等.经动脉骨髓干细胞移植治疗股骨头坏死63例.中国临床康复,2006,10(13):3-5.
34.常炳营,刘亚,田云虎,等.髓芯减压植骨联合BMP植入治疗股骨头坏死的临床观察.潍坊医学院学报,2006,22(1):5-7.
35.李杨,王福剑,曹锡文,等.儿童创伤性股骨头坏死的综合治疗.中国现代药物应用.2007,1(8):15-17.
36.Sternberg ME,Larcom PG,Strafford B,et al.Core decompres-sion withbone grafting for osteonecrosis of the femoral head.Clin Orthop,2001,386(5):71-78.
37.陈峰,肖增明.髓芯减压治疗股骨头缺血性坏死的研究进展[J].医学综述,2006,12(15):925-927.
38.孙永强,程少丹,张国永.非创伤性股骨头坏死临床常用治疗方法分析.中国误诊学杂志.2007,7(24):5794-5796.
39.Leung PC.Femoral head reconstruction and revascularizationtreatment for ischemic necrosis.Clin Orthop,1996,323(1):139-145.
40.张长青,曾炳芳,日圭述平,等.改良吻合血管游离腓骨移植治疗股骨头缺血性坏死的手术技术.中国修复重建外科杂志,2005,9(9):692-696.
41.Scheider W,Aigner N,Pinggera O,et al.lntertrochanteric os-teotomy for vascular necrosis of the femoral head of the femur,survival probability of two different methods.Bone JointSurg(Br),2002,84(1):817-825.
42.Mont MA,Rajadhyaksha AD,Hungerford DS.Outcomes of limited femoral resurfacing arthroplasty compared with hip ar-throplasty for osteonecrosis of the femoral head.J Arthro-plasty,2001,16(1):134-141.
43.肖增明,詹新立,李世德,等.精确匹配的半髋表面置换术治疗股骨头缺血性坏死.中华外科杂志,2006,8(1):17-19.
44.杨述华,杨操,王锐英,等.空心钛支撑架结合自体骨移植治疗股骨头坏死.临床骨科杂志,2005,8(4):289-290.
45.王岩,王继芳,卢世壁,等.网球支架置入治疗成人股骨头缺血性坏死.中华骨科杂志,2000,20(5):295-298.
46.张彦,张长青.股骨头缺血性坏死病程发展及治疗中的生物力学因素.国外医学骨科学分册,2005,26(5):293-294.
47.王义生,殷力,吴学建,等.微创小切口人工全髋关节置换术治疗晚期股骨头坏死.中原医刊,2006,20(1):13-15.
48.Xenakis TA,Gelalis J,Koukoubis TA,et al.Cementless hip arthroplasty in the treatment of patients with femoral head nec-rosis.Clin Orthop,2001,386(5):93-99.
49.Fyda TM,Callaghan JJ,Olejniczak J,et al.Minimum ten-year followup of cemented total hip replacement in patients with os-teonecrosis of the femoral head.Iowa Orthop,2002,22(4):8-19.
50.何齐芳,尚希福.茶黄素抑制激素性股骨头坏死的实验研究.安徽医科大学学报.2007,42(2):415-419.
51.李桂文.四物强骨方治疗股骨头坏死临床疗效观察.广西中医药,2004,27(3):45.
52.臧新开,臧新亚.桂枝芍药知母汤加味治疗股骨头坏死.现代中西医结合杂志,2002, 11(17):1695.
53.刘维立,赵文海,王丹彤.股骨头缺血性坏死治疗常用中药及用药规律.吉林中医药.2007,27(9):53-54.
54.焦红波,刘海英,焦念学.针刺治疗股骨头坏死2例.中医外治杂志,2002,11(3):19.
55.崇桂文.髋三针治疗股骨头坏死的体会.中国针灸,1998,(7):439.
56.白良川,许冠芤,张荣军,等.电针对兔激素性股骨头坏死局部组织血流的影响.安徽中医学院学报.2004,23(1):3.
57.王炳.推拿治疗股骨头缺血性坏死的临床初步探索.按摩与导引.2007,23(7):32-34.
58.孙国辉,董晓俊,覃剑.中药配合小针刀治疗股骨头缺血性坏死的临床观察,中国中医骨伤科杂志.2007,15(10):42-43.
59.钟立清,孟庆云,王平均,等.激素引起股骨头无菌性坏死的介入治疗.淮海医药,2004,22(1):32.
60.韩松辉,郭树农,王锐,等.介入治疗非创伤股骨头缺血性坏死32例临床分析.河南科技大学学报(医学版),2003,21(3):172.
61.葛东泉,张爱珍,马登全,等.中西医结合治疗股骨头缺血性坏死的临床研究.现代中西医结合杂志,2000,9(23):2317.
62.孟广谦,陈永敏.综合疗法治疗股骨头缺血性坏死的研究.中国民族医药杂志.2007,8(9):14-15.
63.杨述华.骨坏死学.北京:人民卫生出版社,2002:7-8.
64.张智慧,昝强.股骨头坏死的非手术治疗进展.甘肃中医学院学报.2006,23(5):48-50.